WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001085722) HETEROBICYCLIC SULFONAMIDES AND THEIR USE AS PLATELET ADP RECEPTOR INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/085722    International Application No.:    PCT/US2001/014441
Publication Date: 15.11.2001 International Filing Date: 04.05.2001
Chapter 2 Demand Filed:    04.12.2001    
IPC:
C07D 409/12 (2006.01), C07D 409/14 (2006.01), C07D 413/12 (2006.01), C07D 413/14 (2006.01), C07D 417/12 (2006.01), C07D 417/14 (2006.01), C07D 495/04 (2006.01), C07D 498/04 (2006.01), C07D 513/04 (2006.01)
Applicants: COR THERAPEUTICS, INC. [US/US]; 256 E. Grand Avenue South San Francisco, CA 94080 (US) (For All Designated States Except US).
SCARBOROUGH, Robert, M. [US/US]; (US) (For US Only).
MARLOWE, Charles, K. [US/US]; (US) (For US Only)
Inventors: SCARBOROUGH, Robert, M.; (US).
MARLOWE, Charles, K.; (US)
Agent: LINDEMAN, Jeffrey, A.; Morgan, Lewis & Bockius LLP 1800 M Street, N.W. Washington, DC 20036-5869 (US)
Priority Data:
60/202,075 05.05.2000 US
60/230,456 06.09.2000 US
Title (EN) HETEROBICYCLIC SULFONAMIDES AND THEIR USE AS PLATELET ADP RECEPTOR INHIBITORS
(FR) SULFONAMIDES HETEROBICYCLIQUES ET UTILISATION DE CELLES-CI COMME INHIBITEURS DE RECEPTEUR ADP DES PLAQUETTES
Abstract: front page image
(EN)The invention relates to novel compounds of formula (I) containing benzofused heterocyclic sulfonamide derivatives which are effective platelet ADP receptor inhibitors. Such compounds including pharmaceutically acceptable salts are useful in various pharmaceutical compositions for the prevention and/or treatment of cardiovascular disease particularly those related to thrombosis.
(FR)La présente invention concerne de nouveaux composés représentés par la formule (I), contenant des dérivés de sulfonamides hétérobicycliques benzocondensés qui sont des inhibiteurs de récepteur ADP des plaquettes efficaces. Ces composés comprenant des sels pharmaceutiquement acceptables conviennent dans diverses compositions pharmaceutiques destinées à la prévention et au traitement de maladies cardio-vasculaires et en particulier de celles qui sont liées aux thromboses.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)